About Eyedaptic
Eyedaptic is a Healthcare company based in Laguna Niguel (United States) founded in 2016. A wearable augmented reality vision assistance solution. Eyedaptic has raised $1.42 million across 3 funding rounds. Its chief executive, as recorded, is Jay Cormier. Eyedaptic offers products and services including EYE6, EYE5, and Accessories. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Eyedaptic Inc. Its competitors include Kodiak Sciences, Second Sight and iScience Interventional; 3 of its 3 listed competitors have raised funding.
Company details
Eyedaptic was founded in 2016 and is based in Laguna Niguel, United States. A wearable augmented reality solution is being developed by the company to assist individuals with age-related macular degeneration and other retinal diseases. Operations focus on health technology within the augmented reality sector, with emphasis on vision enhancement devices. Services target medical assistance for visual impairments, supporting affected populations through innovative wearables.
- Headquarters Laguna Niguel, United States
- SectorsHealthcare
- Website eyedaptic.com
- Social LinkedIn X Facebook
- Legal Name Eyedaptic Inc.
- Annual Revenue$458.41 K (USD)116as on Dec 31, 2023
- Net Profit-$686.97 K (USD)-1as on Dec 31, 2023
- Total Equity Funding$1.42M (USD)
in 3 rounds
- Latest Funding Round$597.5K (USD), Seed
Dec 2019
Products & Services of Eyedaptic
Eyedaptic offers a comprehensive portfolio of products and services, including EYE6, EYE5, and Accessories.
AI-enhanced glasses for vision optimization in AMD patients.
Wearable device aiding low vision through AR technology.
Complementary items for Eyedaptic smart glasses users.
Funding Insights of Eyedaptic
Eyedaptic has successfully raised a total of $1.42M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $597.5 thousand completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.42M
- Total Rounds 3
- Last Round Seed — $597,500
- First Round $550,000
(Aug 2017)
All 3 funding rounds of Eyedaptic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2019 | $597,500 | Seed | – | – | – |
| May 2018 | $275,000 | Seed | – | – | – |
| Aug 2017 | $550,000 | Seed | – | – | – |
People of Eyedaptic
1 people are tracked at Eyedaptic (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jay Cormier | CEO & President | Leadership |
Complete people profiles for Eyedaptic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Eyedaptic
3 dated milestones of Eyedaptic across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Eyedaptic is founded.
- Funding First funding round of $550K.
- Funding Latest funding round, Seed, of $598K.
Competitors of Eyedaptic
Eyedaptic has 3 listed competitors in our database, 3 of them funded. They include Kodiak Sciences, Second Sight and iScience Interventional.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kodiak.com | 2009 | Palo Alto, United States | $35.84M | 112 | Therapeutics for retinal diseases are developed by the company. | |
| secondsight.com | 2000 | Los Angeles, United States | $52.3M | 14 | Implantable visual prosthetics for blind individuals are developed and provided. | |
| iscienceinterventional.com | 1999 | Menlo Park, United States | $36.68M | Microcatheter and imaging technologies for ophthalmic procedures are developed. |
Detailed competitors of Eyedaptic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Eyedaptic
The website of Eyedaptic (eyedaptic.com) receives about 4.1K visits a month.
- Monthly visits4.1K
▲ 71.7% vs previous month
Websites whose visitors overlap most with Eyedaptic. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| floridareading.com | 100% | #3,783,417 | View details |
Top companies in Ophthalmology
3 companies that operate in the same segment as Eyedaptic (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eyedaptic
Complete news archive for Eyedaptic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eyedaptic
Eyedaptic was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Eyedaptic is headquartered in Laguna Niguel, United States. It is registered at Laguna Niguel, California, United States.
Jay Cormier is the CEO of Eyedaptic, as recorded in our data.
Eyedaptic is a funded company, having raised a total of $1.42M across 3 funding rounds to date. The company's 1st funding round was a Seed of $550K, raised on Aug 2017.
Annual revenue of Eyedaptic is $458.41K as on Dec 31, 2023.
Eyedaptic was founded in 2016 and is based in Laguna Niguel, United States. A wearable augmented reality solution is being developed by the company to assist individuals with age-related macular degeneration and other retinal diseases. Operations focus on health technology within the augmented reality sector, with emphasis on vision enhancement devices. Services target medical assistance for visual impairments, supporting affected populations through innovative wearables.
Eyedaptic's top competitors include Kodiak Sciences, Second Sight and iScience Interventional.
Eyedaptic offers EYE6, EYE5, and Accessories.
Eyedaptic operates through Eyedaptic Inc..